Longevity Week London: Key quotes and articles

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

Last week was a big turning point in Longevity: In key centres of academic and scientific endeavour the key players in Longevity aligned.

The three intense days of meetings during Longevity Week London were a key turning point. If you were sceptical about Longevity, or didn’t understand it, the opinions and clarifications delivered by leaders in the sector would have left you in no doubt that the sector is set to address one of the biggest issues and opportunities facing humankind:

Jim Mellon: “If we are going to live to 110-120 the best thing is to invest in the thing that’ll help you get there.”

Dr Aubrey de Grey: “SENS has always been funded through philanthropy to bypass the tyranny of peer review. We don’t work on Longevity, whatever the media may like to tell you. However, we know that our work will increase longevity a lot, I mean really a lot, and yes, we think this is a good side-effect.”

Dmitry Kaminskiy: “Longevity is becoming mainstream among scientists, entrepreneurs, investors, major financial, tech and healthcare corporations, and progressive governments. AI holds unprecedented power to translate research into tangible solutions to extend healthy longevity …”

Dr Nir Barzilai: “Aging is the major risk for heart disease, aging drives diseases. There’s only one thing that we can do and that is target aging which is really the risk for all major diseases.”

Ovarian Longevity webinar

Dr Mike West: “Aging is reprogrammable … I think that Washington doesn’t have a clue and I’m sure the public has no idea.”

Richard Siow: AI holds enormous potential to rapidly accelerate the implementation of Longevity R&D … our unique academic-industry focus on preventive and personalised physical, mental and financial health, marking us out from other AI and Ageing centres around the world” said ,

Julia Randell-Khan: “We don’t see long life being a problem, but we have economic systems that are based on life being half as long … People need the answers to questions like, ‘How am I going to afford to retire and how am I going to survive dementia?’ The multi-stage lives that we are now all living means that we need a sense of belonging, sense and worth.” 

Otani Soshi, Japan: “We need to redesign the system. If we allowed citizens to work an extra 10 years between the ages of 65 and 75 we could rebalance the social security system to what it was 15 years ago.”

Ovarian Longevity webinar

Jim Mellon: “… we’re the first generation on the planet for whom bioengineering is possible but subsequently stem cells, organ and tissue regeneration and then ultimately gene editing are the things which will keep people alive to 110 or 120. We think those technologies are here today but gene editing will be the reason why the first person to be alive to 150 is living amongst us today.”

These are some of the key articles from last week:

London addresses the 100 year life. Get ready!

Small rooms, big opportunities

First Longevity AI Consortium launched at King’s

Longevity Forum 2019 and the 150 year life

Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

SENS spin-out Underdog closes $10m financing round

Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital. Michael Greve’s Kizoo Technology Capital Group led the...

Unlocking ovarian aging could prolong fertility and delay menopause

Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery. Silicon Valley biotech startup...

Targeting cognitive decline with medical food

Mitocholine raising funding for clinical trial of nutritional compound that addresses cognitive decline by bridging the ‘brain energy gap’. DISCLOSURE: Longevity.Technology (a brand of First...
Nutriop